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Objective
Current diabetes care is considered as insufficient
regarding early diagnostics, targeted prevention and
treatments tailored to the person. Further, gender speci-
fic diagnostics and treatment are not the issue of cur-
rently applied medical services in diabetes care. This is
to understand status quo in diabetes complications and
co-morbidities more typical for the female sub-
populations.
Material and methods
Pubmed literature search within the years 1980-2013 [1].
Results and interpretation
Cardiovascular disease (CVD) is the best acknowledged
complication in patients with Diabetes mellitus type 1
and type 2. It has been well documented that female
diabetics demonstrate poorer outcomes of CVD. A com-
bination of the female gender and diabetes is the best
recognised risk factor for high operation mortality by
and low efficacy of the replacement of calcified valves
[2]. Further, cardiovascular diseased women, in particu-
lar female diabetics, have poorer prognosis of oncologic
diseases. The most frequent oncologic complications
and co-morbidities in female diabetics are the following
ones [3,4]:
❖ endomentrium carcinoma (4.8-times higher preva-
lence in type 1 diabetes and 2.2-times higher in diabetes
generally)
❖ ovarian carcinoma (2.42-times higher risk in female
diabetics versus general female subpopulation)
❖ liver cancer (2.0-times higher risk)
❖ lymphoma (1.9-times higher risk)
❖ uterus carcinoma (1.7-times higher risk)
❖ rectum cancer (1.7-times higher risk)
❖ stomach cancer (1.6-times higher risk)
❖ leukaemia (1.4-times higher risk)
❖ kidney cancer (1.4-times higher risk)
❖ pancreatic cancer (1.3-times higher risk)
❖ breast cancer (1.2-times higher risk)
❖ lung cancer (1.1-times higher risk).
Conclusions
Common risk factors moderating the outcomes in the
most frequent female pathologies, namely DM type 2,
CVD and breast cancer are progressing age, overweight,
poor diet, physical inactivity and depression. Modifiable
risk factors persist from childhood and adolescence into
adulthood and tend to cluster with synergistic negative
effects for consequent manifestation of co-morbid
pathologies [5]. However, there are significant knowl-
edge deficits concerning “typical” versus “atypical” co-
morbidity profiles in diabetic females.
Recommendations
Although the coincidence is common in women, consis-
tent data do not exist to recognise complications and
co-morbid pathologies by patient profiling. Complica-
tions and complex clinical situations in elderly popula-
tions should be considered as the persistent challenge
that requires new strategies in healthcare. Integrative
medical approaches are strongly desirable to analyse
common risk factors as well as their individual and
synergistic effects. Frequent versus rare complication
profiles in cardiovascular diseased patient cohorts
should be created for advanced treatment regiments.
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